Maryann Banerji

This study compares how two types of FDA-approved diabetes medications affect the pancreas's ability to produce insulin in Black patients with type 2 diabetes. Sixty participants will take either a GLP-1 receptor agonist (like Ozempic) or an SGLT2 inhibitor (like Jardiance) for f…